A detailed history of Natixis Advisors, L.P. transactions in Pfizer Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 2,397,900 shares of PFE stock, worth $61.3 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
2,397,900
Previous 2,601,416 7.82%
Holding current value
$61.3 Million
Previous $72.8 Million 4.66%
% of portfolio
0.14%
Previous 0.16%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$27.7 - $31.39 $5.64 Million - $6.39 Million
-203,516 Reduced 7.82%
2,397,900 $69.4 Million
Q2 2024

Aug 01, 2024

BUY
$25.26 - $29.6 $9.8 Million - $11.5 Million
387,856 Added 17.52%
2,601,416 $72.8 Million
Q1 2024

Apr 25, 2024

BUY
$25.89 - $29.73 $25.4 Million - $29.1 Million
980,321 Added 79.49%
2,213,560 $61.4 Million
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $4.12 Million - $5.35 Million
-157,733 Reduced 11.34%
1,233,239 $35.5 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $34.1 Million - $39.8 Million
-1,061,722 Reduced 43.29%
1,390,972 $46.1 Million
Q2 2023

Aug 15, 2023

BUY
$36.12 - $41.79 $44.5 Million - $51.5 Million
1,232,948 Added 101.08%
2,452,694 $90 Million
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $36.5 Million - $47.6 Million
-927,861 Reduced 43.2%
1,219,746 $49.8 Million
Q4 2022

Jan 27, 2023

BUY
$41.75 - $54.5 $34.1 Million - $44.5 Million
816,561 Added 61.35%
2,147,607 $110 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $13.9 Million - $17 Million
-317,452 Reduced 19.26%
1,331,046 $58.2 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $2.37 Million - $2.81 Million
50,997 Added 3.19%
1,648,498 $86.4 Million
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $21.9 Million - $27.1 Million
478,224 Added 42.73%
1,597,501 $82.7 Million
Q4 2021

Feb 08, 2022

BUY
$41.32 - $61.25 $10.5 Million - $15.5 Million
253,047 Added 29.21%
1,119,277 $66.1 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $260,894 - $335,141
6,647 Added 0.77%
866,230 $37.3 Million
Q2 2021

Aug 12, 2021

BUY
$35.91 - $40.68 $2.35 Million - $2.67 Million
65,556 Added 8.26%
859,583 $33.7 Million
Q1 2021

May 05, 2021

SELL
$33.49 - $37.77 $1.66 Million - $1.87 Million
-49,574 Reduced 5.88%
794,027 $28.8 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $6.06 Million - $7.7 Million
-180,987 Reduced 17.66%
843,601 $31.1 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $5.17 Million - $6.06 Million
-162,700 Reduced 13.7%
1,024,588 $37.6 Million
Q2 2020

Aug 11, 2020

SELL
$30.12 - $36.54 $820,980 - $995,970
-27,257 Reduced 2.24%
1,187,288 $38.8 Million
Q1 2020

Apr 27, 2020

SELL
$27.03 - $38.62 $5.38 Million - $7.69 Million
-199,145 Reduced 14.09%
1,214,545 $39.6 Million
Q4 2019

Feb 10, 2020

BUY
$32.92 - $37.36 $8.17 Million - $9.27 Million
248,209 Added 21.3%
1,413,690 $55.4 Million
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $5.5 Million - $7.13 Million
-169,157 Reduced 12.67%
1,165,481 $41.9 Million
Q2 2019

Aug 12, 2019

SELL
$36.98 - $41.52 $848,838 - $953,050
-22,954 Reduced 1.69%
1,334,638 $57.8 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $3.78 Million - $4.16 Million
-100,855 Reduced 6.92%
1,357,592 $57.7 Million
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $832,490 - $949,130
21,640 Added 1.51%
1,458,447 $63.7 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $4.53 Million - $5.49 Million
-131,372 Reduced 8.38%
1,436,807 $63.3 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $2.23 Million - $2.38 Million
67,738 Added 4.51%
1,568,179 $0
Q1 2018

May 10, 2018

BUY
$31.91 - $37.02 $1.3 Million - $1.51 Million
40,754 Added 2.79%
1,500,441 $53.3 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $653,658 - $693,554
19,653 Added 1.36%
1,459,687 $52.9 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $44.6 Million - $49.2 Million
1,440,034
1,440,034 $51.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $143B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.